219 related articles for article (PubMed ID: 10934117)
1. Increased risk of fibrosing alveolitis associated with interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphisms.
Whyte M; Hubbard R; Meliconi R; Whidborne M; Eaton V; Bingle C; Timms J; Duff G; Facchini A; Pacilli A; Fabbri M; Hall I; Britton J; Johnston I; Di Giovine F
Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):755-8. PubMed ID: 10934117
[TBL] [Abstract][Full Text] [Related]
2. [Relationship between interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms and susceptibility to gastric cancer].
He X; Jiang L; Fu B; Zhang X
Zhonghua Yi Xue Za Zhi; 2002 May; 82(10):685-8. PubMed ID: 12133467
[TBL] [Abstract][Full Text] [Related]
3. Smoking and polymorphisms of the interleukin-1 gene cluster (IL-1alpha, IL-1beta, and IL-1RN) in patients with periodontal disease.
Meisel P; Siegemund A; Dombrowa S; Sawaf H; Fanghaenel J; Kocher T
J Periodontol; 2002 Jan; 73(1):27-32. PubMed ID: 11846196
[TBL] [Abstract][Full Text] [Related]
4. Cytokine gene polymorphisms in gastric cancer patients from two Italian areas at high and low cancer prevalence.
Perri F; Piepoli A; Bonvicini C; Gentile A; Quitadamo M; Di Candia M; Cotugno R; Cattaneo F; Zagari MR; Ricciardiello L; Gennarelli M; Bazzoli F; Ranzani GN; Andriulli A
Cytokine; 2005 Jun; 30(5):293-302. PubMed ID: 15927855
[TBL] [Abstract][Full Text] [Related]
5. Impact of interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphism on IgA nephropathy.
Shu KH; Lee SH; Cheng CH; Wu MJ; Lian JD
Kidney Int; 2000 Aug; 58(2):783-9. PubMed ID: 10916103
[TBL] [Abstract][Full Text] [Related]
6. Neither IL-1beta, IL-1 receptor antagonist, nor TNF-alpha polymorphisms are associated with susceptibility to COPD.
Ishii T; Matsuse T; Teramoto S; Matsui H; Miyao M; Hosoi T; Takahashi H; Fukuchi Y; Ouchi Y
Respir Med; 2000 Sep; 94(9):847-51. PubMed ID: 11001075
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility for and clinical manifestations of rheumatoid arthritis are associated with polymorphisms of the TNF-alpha, IL-1beta, and IL-1Ra genes.
Cvetkovic JT; Wallberg-Jonsson S; Stegmayr B; Rantapaa-Dahlqvist S; Lefvert AK
J Rheumatol; 2002 Feb; 29(2):212-9. PubMed ID: 11838837
[TBL] [Abstract][Full Text] [Related]
8. Interleukin (IL)-1 gene polymorphisms: relevance of disease severity associated alleles with IL-1beta and IL-1ra production in multiple sclerosis.
Schrijver HM; van As J; Crusius JB; Dijkstra CD; Uitdehaag BM
Mediators Inflamm; 2003 Apr; 12(2):89-94. PubMed ID: 12775358
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 1 receptor antagonist and tumor necrosis factor-alpha gene polymorphism in patients with end-stage renal failure.
Shu KH; Cheng CH; Wu MJ; Chen CH; Lee WC
Ren Fail; 2005; 27(1):53-7. PubMed ID: 15717635
[TBL] [Abstract][Full Text] [Related]
10. Evidence against a role for polymorphisms at tumor necrosis factor, interleukin-1 and interleukin-1 receptor antagonist gene loci in the regulation of disease severity in acute pancreatitis.
Powell JJ; Fearon KC; Siriwardena AK; Ross JA
Surgery; 2001 May; 129(5):633-40. PubMed ID: 11331456
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility for ischemic stroke in Korean population is associated with polymorphisms of the interleukin-1 receptor antagonist and tumor necrosis factor-alpha genes, but not the interleukin-1beta gene.
Lee BC; Ahn SY; Doo HK; Yim SV; Lee HJ; Jin SY; Hong SJ; Lee SH; Kim SD; Seo JC; Leem KH; Chung JH
Neurosci Lett; 2004 Feb; 357(1):33-6. PubMed ID: 15036607
[TBL] [Abstract][Full Text] [Related]
12. Polymorphism of the cytokine genes and IgA nephropathy.
Syrjänen J; Hurme M; Lehtimäki T; Mustonen J; Pasternack A
Kidney Int; 2002 Mar; 61(3):1079-85. PubMed ID: 11849463
[TBL] [Abstract][Full Text] [Related]
13. Osteoporotic fractures are associated with an 86-base pair repeat polymorphism in the interleukin-1--receptor antagonist gene but not with polymorphisms in the interleukin-1beta gene.
Langdahl BL; Løkke E; Carstens M; Stenkjaer LL; Eriksen EF
J Bone Miner Res; 2000 Mar; 15(3):402-14. PubMed ID: 10750554
[TBL] [Abstract][Full Text] [Related]
14. Genotypic and functional roles of IL-1B and IL-1RN on the risk of gastroesophageal reflux disease: the presence of IL-1B-511*T/IL-1RN*1 (T1) haplotype may protect against the disease.
Chourasia D; Achyut BR; Tripathi S; Mittal B; Mittal RD; Ghoshal UC
Am J Gastroenterol; 2009 Nov; 104(11):2704-13. PubMed ID: 19603010
[TBL] [Abstract][Full Text] [Related]
15. Gene polymorphisms of TNF-alpha-308 (G/A), IL-10(-1082) (G/A), IL-6(-174) (G/C) and IL-1Ra (VNTR) in Egyptian cases with type 1 diabetes mellitus.
Settin A; Ismail A; El-Magd MA; El-Baz R; Kazamel A
Autoimmunity; 2009 Jan; 42(1):50-5. PubMed ID: 19127455
[TBL] [Abstract][Full Text] [Related]
16. Association of IL-1beta, IL-1ra, and TNF-alpha gene polymorphisms in childhood nephrotic syndrome.
Kim SD; Park JM; Kim IS; Choi KD; Lee BC; Lee SH; Hong SJ; Jin SY; Lee HJ; Hong MS; Chung JH; Lee TW; Ihm CG; Cho BS
Pediatr Nephrol; 2004 Mar; 19(3):295-9. PubMed ID: 14758530
[TBL] [Abstract][Full Text] [Related]
17. Resistance to human cytomegalovirus infection may be influenced by genetic polymorphisms of the tumour necrosis factor-alpha and interleukin-1 receptor antagonist genes.
Hurme M; Helminen M
Scand J Infect Dis; 1998; 30(5):447-9. PubMed ID: 10066041
[TBL] [Abstract][Full Text] [Related]
18. A study on the association of TNF-α(-308), IL-6(-174), IL-10(-1082) and IL-1Ra(VNTR) gene polymorphisms with rheumatic heart disease in Pakistani patients.
Rehman S; Akhtar N; Saba N; Munir S; Ahmed W; Mohyuddin A; Khanum A
Cytokine; 2013 Feb; 61(2):527-31. PubMed ID: 23168096
[TBL] [Abstract][Full Text] [Related]
19. Functional correlates of the interleukin-1 receptor antagonist gene polymorphism in the colonic mucosa in ulcerative colitis.
Carter MJ; Jones S; Camp NJ; Cox A; Mee J; Warren B; Duff GW; Lobo AJ; di Giovine FS
Genes Immun; 2004 Jan; 5(1):8-15. PubMed ID: 14735144
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in the IL-1 receptor antagonist gene VNTR are possible risk factors for juvenile idiopathic inflammatory myopathies.
Rider LG; Artlett CM; Foster CB; Ahmed A; Neeman T; Chanock SJ; Jimenez SA; Miller FW
Clin Exp Immunol; 2000 Jul; 121(1):47-52. PubMed ID: 10886238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
